advisorsecurities master

ASMBAssembly Biosciences, Inc

CSNasdaq (XNAS)·USD

Identity

Security key
11957
Ticker
ASMB
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2010-12-17
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ASMB

Detail

Enriched 2026-08-14 20:47

Market cap
$536,254,785
Shares outstanding (class)
15,892,608
Shares outstanding (weighted)
19,817,250
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
73
Location
SOUTH SAN FRANCISCO, CA
Description

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data